{"id":162630,"date":"2022-06-28T01:47:30","date_gmt":"2022-06-28T05:47:30","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/press-release-nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe\/"},"modified":"2024-08-18T11:44:52","modified_gmt":"2024-08-18T15:44:52","slug":"press-release-nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe.php","title":{"rendered":"Press Release: Nexviadyme\u00ae (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe&#8230;"},"content":{"rendered":"<p><![CDATA[Nexviadyme\u00ae (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe Disease]]><\/p>\n<p>See the original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/28\/2469979\/0\/en\/Press-Release-Nexviadyme-avalglucosidase-alfa-approved-by-European-Commission-as-a-potential-new-standard-of-care-for-the-treatment-of-Pompe-Disease.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Press Release: Nexviadyme\u00ae (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe...\">Press Release: Nexviadyme\u00ae (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the original post: Press Release: Nexviadyme\u00ae (avalglucosidase alfa) approved by European Commission as a potential new standard of care for the treatment of Pompe... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/press-release-nexviadyme-avalglucosidase-alfa-approved-by-european-commission-as-a-potential-new-standard-of-care-for-the-treatment-of-pompe.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162630","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162630"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162630"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162630\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162630"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162630"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}